About: Coronavirus Vaccine: Light at the End of the Tunnel

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Coronavirus Vaccine: Light at the End of the Tunnel Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Coronavirus Vaccine: Light at the End of the Tunnel
Creator	Mohan, V Ella, Krishna Mohan, Krishna
Source	Medline; PMC
abstract	The world is currently facing an unprecedented global pandemic caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Predicting the next source of the pandemic can be very challenging. As vaccination is the best way to prevent an infectious disease, the development of an effective vaccine against SARS-CoV-2 can not only reduce the morbidity and mortality associated with it, but can also lessen the economic impact. As the traditional method of vaccine development takes many years for a vaccine to be available to the society, the vaccine development for SARS-CoV-2 should be speeded up using a pandemic approach with fast-track approvals from the regulatory authorities. Various challenges associated with developing a vaccine during the pandemic such as technological hurdles, clinical development pathways, regulatory issues, and support from global funding agencies are expressed here.
has issue date	2020-04-15(xsd:dateTime)
bibo:doi	10.1007/s13312-020-1812-z
bibo:pmid	32291382
has license	no-cc
sha1sum (hex)	98f4abb7b6e0854450555e30926bc8f299661530
schema:url	https://doi.org/10.1007/s13312-020-1812-z
resource representing a document's title	Coronavirus Vaccine: Light at the End of the Tunnel
has PubMed Central identifier	PMC7240229
has PubMed identifier	32291382
schema:publication	Indian Pediatr
resource representing a document's body	covid:98f4abb7b6e0854450555e30926bc8f299661530#body_text
is schema:about of	named entity 'vaccination' named entity 'vaccine' named entity 'placebo' named entity 'protein' named entity 'vaccine' named entity 'virus' named entity 'immune responses' named entity 'Global pandemic' named entity 'infectious diseases' named entity 'Preclinical' named entity 'COVID-19' named entity 'phase IV' named entity 'SARS' named entity 'viruses' named entity 'pathogens' named entity 'vaccine' named entity 'Middle East Respiratory Syndrome Coronavirus' named entity 'vaccine' named entity 'vaccination' named entity 'morbidity' named entity 'vaccine' named entity 'vaccine' named entity 'World Bank' named entity 'vaccine' named entity 'low and middle income countries' named entity 'COVID-19 vaccine' named entity 'vaccine' named entity 'vaccine' named entity 'influenza' named entity 'CEPI' named entity 'vaccine' named entity 'WHO' named entity 'GMP' named entity 'vaccine' named entity 'morbidity' named entity 'vaccine' named entity 'public health' named entity 'Vaccine' named entity 'vaccine' named entity 'COVID-19 pandemic' named entity 'immunogen' named entity 'S protein' named entity 'vaccine' named entity 'MERS' named entity 'vaccine' named entity 'Vaccine' named entity 'COVID-19 vaccine' named entity 'vaccine' named entity 'host cell receptor' named entity 'COVID-19' named entity 'vaccine' named entity 'clinical trial' named entity 'virus' named entity 'GMP' named entity 'Correlates of protection' named entity 'virulent form of influenza' named entity 'innovative financing' named entity 'Global Alliance for Vaccines and Immunizations' named entity 'clinical trials' named entity 'LIGHT AT THE END' named entity 'protein subunit' named entity 'virus' named entity 'Good Manufacturing Practices' named entity 'public health' named entity 'supply and demand' named entity 'Middle East Respiratory Syndrome' named entity 'viral vector' named entity 'GMP' named entity 'SARS' named entity 'Angiotensin-Converting Enzyme' named entity 'infection' named entity 'infection' named entity 'vaccine' named entity 'SARS-CoV-2' named entity 'vaccine' named entity 'GAVI' named entity 'vaccine' named entity 'infectivity' named entity 'supply chain'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software